Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2013
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PETYelena Y Janjigian, Nerissa Viola-Villegas, Jason P Holland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2012
Imaging tumor burden in the brain with 89Zr-transferrinMichael J Evans, Jason P Holland, Samuel L Rice, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
<sup>89</sup>Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient SelectionEric W Price, Kathryn E Carnazza, Sean D Carlin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2012
Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in ratsRachel M Bartlett, Bradley J Beattie, Manoj Naryanan, et al.
Scientific Reports|June 15, 2018
Imaging EGFR and HER3 through <sup>89</sup>Zr-labeled MEHD7945A (Duligotuzumab)Brooke N McKnight, Akhila N W Kuda-Wedagedara, Kuntal K Sevak, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain DormancyAmulya Sreekumar, Eric Blankemeyer, Christopher J Sterner, et al.
Cancer Discovery|December 10, 2025
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain DormancyAmulya Sreekumar, Eric Blankemeyer, Christopher J Sterner, et al.
Bioconjugate Chemistry|July 12, 2016
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization StudyDustin Wayne Demoin, Linden C Wyatt, Kimberly J Edwards, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2014
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancerNerissa Therese Viola-Villegas, Sean D Carlin, Ellen Ackerstaff, et al.
EJNMMI Research|June 5, 2013
Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancerJoseph A O'Donoghue, José G Guillem, Heiko Schöder, et al.
Pageof 4